{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T21:23:58Z","timestamp":1787606638645,"version":"build-2736575974"},"reference-count":24,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Form Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec sec-type=\"background\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>As the global population ages, Parkinson disease (PD) has emerged as the second most prevalent neurodegenerative condition after Alzheimer disease. People with PD often experience speech problems, including reduced volume, monotone pitch, breathiness, and word slurring. Interventions such as speech therapy through mobile apps provide reassurance and easier access to care for patients having this neurodegenerative condition. Mobile apps offer patients with PD greater access to care and the reassurance of being able to manage their condition at home. However, we do not know the quality of these apps. A systematic evaluation of these mobile apps is necessary to ensure their effectiveness and suitability for use by patients with PD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"objective\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to evaluate the quality of existing free apps that support speech therapy for people with PD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study took place at Weill Cornell Medicine in New York, New York. It was conducted between January 2024 and July 2025. We conducted a systematic application search to identify apps available on the Apple App Store for speech therapy targeting people with PD and then performed an evaluation using the Mobile App Rating Scale framework with 4 raters. We only included freely available apps. We calculated interrater reliability and found median and mean ratings and SD for Mobile App Rating Scale dimensions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      From 33 candidate apps, we included 3 apps in our evaluation. Functionality scored high for all 3 apps, with ratings above 4.5. However, engagement scored the lowest in all the apps. Interrater reliability agreement varied for all sections.\n                      <jats:italic>Voicibel<\/jats:italic>\n                      had the highest agreement of 0.83 for engagement. Aesthetics had the lowest agreement in all 3 apps, with agreements at 0.33 or below.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>All 3 apps offer targeted exercises and are targeted for the patient. Mobile apps hold promise for increasing the accessibility of speech therapy for patients with PD and provide promising support for managing speech difficulties in PD. Evaluating these apps is essential to determine their quality in supporting these patients. Future research with speech therapy apps should evaluate clinical efficacy through randomized controlled trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/72214","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T12:55:06Z","timestamp":1784033706000},"page":"e72214-e72214","source":"Crossref","is-referenced-by-count":0,"title":["Quality Evaluation Using the Mobile App Rating Scale for Speech Therapy in Parkinson Disease: Systematic Search and Evaluation"],"prefix":"10.2196","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7808-1465","authenticated-orcid":false,"given":"Tooba","family":"Haris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1793-3160","authenticated-orcid":false,"given":"Harshvi","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9083-0195","authenticated-orcid":false,"given":"Jose F","family":"Florez-Arango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8740732","article-title":"Autonomic dysfunctions in Parkinson\u2019s disease: prevalence, clinical characteristics, potential diagnostic markers, and treatment","volume":"2020","author":"Zhang","journal-title":"Parkinsons Dis"},{"key":"R2","unstructured":"Zafar S Lui F Yaddanapudi SS . Parkinson Disease. StatPearls Publishing; 2025. [Medline: 29261972]"},{"issue":"10291","key":"R3","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s disease","volume":"397","author":"Bloem","journal-title":"Lancet"},{"issue":"8","key":"R4","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","article-title":"Parkinson\u2019s disease: etiopathogenesis and treatment","volume":"91","author":"Jankovic","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"R5","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2217\/nmt-2018-0021","article-title":"Speech disorders in Parkinson\u2019s disease: pathophysiology, medical management and surgical approaches","volume":"8","author":"Dashtipour","journal-title":"Neurodegener Dis Manag"},{"issue":"1","key":"R6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/s0094-730x(03)00005-6","article-title":"Parkinsonian speech disfluencies: effects of L-dopa-related fluctuations","volume":"28","author":"Goberman","journal-title":"J Fluency Disord"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcomdis.2020.106031","article-title":"The impact of Lee Silverman Voice Treatment (LSVT LOUD\u00ae) on voice, communication, and participation: findings from a prospective, longitudinal study","volume":"89","author":"Bryans","journal-title":"J Commun Disord"},{"issue":"10","key":"R8","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1097\/01.mlg.0000232537.58310.22","article-title":"Clinical evaluation of Parkinson\u2019s-related dysphonia","volume":"116","author":"Sewall","journal-title":"Laryngoscope"},{"issue":"7","key":"R9","doi-asserted-by":"publisher","DOI":"10.2196\/30621","article-title":"Implementation and effects of an information technology-based intervention to support speech and language therapy among stroke patients with aphasia: protocol for a virtual randomized controlled trial","volume":"10","author":"Kim","journal-title":"JMIR Res Protoc"},{"key":"R10","doi-asserted-by":"crossref","unstructured":"Apandi AM . Gamification meets mobile learning: soft-skills enhancement. In: Raman A Rathakrishnan M , editors. Redesigning Higher Education Initiatives for Industry 4.0. IGI Global; 2019:141-161. [doi: 10.4018\/978-1-5225-7832-1.ch009]","DOI":"10.4018\/978-1-5225-7832-1.ch009"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.2196\/45207","article-title":"The effectiveness of digital apps providing personalized exercise videos: systematic review with meta-analysis","volume":"25","author":"Davergne","journal-title":"J Med Internet Res"},{"issue":"2","key":"R12","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.3390\/ijerph110201279","article-title":"A review of telehealth service implementation frameworks","volume":"11","author":"van Dyk","journal-title":"Int J Environ Res Public Health"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","journal-title":"BMJ"},{"issue":"11","key":"R14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0241480","article-title":"Validation of the Mobile Application Rating Scale (MARS)","volume":"15","author":"Terhorst","journal-title":"PLoS One"},{"issue":"3","key":"R15","first-page":"276","volume":"22","author":"McHugh","journal-title":"Biochem Med (Zagreb)"},{"key":"R16","unstructured":"Hartling L Hamm M Milne A . Interpretation of fleiss\u2019 kappa (\u03ba) (from Landis and Koch 1977). Agency for Healthcare Research and Quality (US); 2012. URL: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK92287\/table\/executivesummary.t2\/ [Accessed 13-03-2026]"},{"issue":"2","key":"R17","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10484-006-9014-6","article-title":"The influence of voice volume, pitch, and speech rate on progressive relaxation training: application of methods from speech pathology and audiology","volume":"31","author":"Knowlton","journal-title":"Appl Psychophysiol Biofeedback"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102823","article-title":"Effectiveness of remotely delivered speech therapy in persons with Parkinson\u2019s disease\u2014a randomised controlled trial","volume":"76","author":"Maas","journal-title":"EClinicalMedicine"},{"issue":"4","key":"R19","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000484556","article-title":"The Radboud Dysarthria Assessment: development and clinimetric evaluation","volume":"69","author":"Knuijt","journal-title":"Folia Phoniatr Logop"},{"issue":"3","key":"R20","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.sapharm.2012.04.004","article-title":"Interrater agreement and interrater reliability: key concepts, approaches, and applications","volume":"9","author":"Gisev","journal-title":"Res Social Adm Pharm"},{"issue":"1","key":"R21","doi-asserted-by":"publisher","DOI":"10.2196\/63166","article-title":"Smartphone application-based voice and speech training program for Parkinson disease: feasibility and satisfaction study with a preliminary rater-blinded single-arm pretest and posttest design","volume":"27","author":"Lee","journal-title":"J Med Internet Res"},{"issue":"1","key":"R22","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/bs.pbr.2022.01.017","article-title":"Speech dysfunction, cognition, and Parkinson's disease","volume":"269","author":"Rohl","journal-title":"Prog Brain Res"},{"issue":"4","key":"R23","doi-asserted-by":"publisher","DOI":"10.3390\/biom11040612","article-title":"Treatment options for motor and non-motor symptoms of Parkinson's disease","volume":"11","author":"Church","journal-title":"Biomolecules"},{"issue":"1","key":"R24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3233\/JPD-230117","article-title":"Delivering multidisciplinary rehabilitation care in Parkinson's disease: an international consensus statement","volume":"14","author":"Goldman","journal-title":"J Parkinsons Dis"}],"container-title":["JMIR Formative Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T21:01:57Z","timestamp":1787605317000},"score":1,"resource":{"primary":{"URL":"https:\/\/formative.jmir.org\/2026\/1\/e72214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":24,"URL":"https:\/\/doi.org\/10.2196\/72214","relation":{},"ISSN":["2561-326X"],"issn-type":[{"value":"2561-326X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]},"article-number":"v10i10291e72214"}}